{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:51:58Z","timestamp":1784303518011,"version":"3.55.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>TB is the most frequent opportunistic infection and cause of death among People living with HIV\/AIDS. Human immunodeficiency virus-positive individuals are routinely screened for tuberculosis as a means of monitoring efforts to mitigate the consequences of the disease on HIV-positive patients. TB status assessment identifies HIV-positive clients who show no evidence of active TB by symptom screening and would benefit from treatment with isoniazid for prevention of TB disease among HIV positives.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>\nMethods\n<\/jats:title>\n<jats:p>A facility-based cross-sectional study design was conducted in public health facilities of West Shewa Zone from January to February 2019. Of the 28 Public health facilities providing HIV\/AIDS care and support (HCT and ART services) 13 of them were selected by simple random sampling techniques. Finally, 815 study participants were recruited by systematics sampling techniques &amp; proportional sample size allocation was applied depending on the HIV patient load in each health facility. After reviewing relevant literature, a structured questionnaire adapted from standardized WHO guidelines, prepared for monitoring &amp; evaluation of TB\/HIV activities was used to collect data via interviewer.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>Of the total, 769 (94.4%) PLHIV were screened for tuberculosis, among which 212 (27.6%) were found to be positive for active tuberculosis. Among 557 (72.4%) individuals eligible for IPT, only 300 (53.9%) were provided IPT; 257 (46.1%) eligible PLHIV were not provided IPT. Resident (adjusted odds ratio [AOR] 5.6), those who didn\u2019t attend school (AOR 4.0), primary school (grade 1-8) (AOR 3.2), and secondary school (grade 9-12) (AOR 4.2) were significantly associated with the likelihood of tuberculosis infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>\nConclusion\n<\/jats:title>\n<jats:p>The present study findings demonstrated that tuberculosis screening for PLHIV at West Shewa Zone public health facilities was improved in comparison with reports from many African countries and other parts of Ethiopia. The IPT implementation rate fell short of both national and WHO guidelines, notwithstanding this improvement. In the study area, diagnostic methods for tuberculosis and existing preventive measures should be improved overall.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0319676","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:30:13Z","timestamp":1741627813000},"page":"e0319676","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-2353","authenticated-orcid":true,"given":"Mecha","family":"Aboma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayisa","family":"Abdisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudata","family":"Imana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefyalew","family":"Taye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonfa","family":"Moti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merob","family":"Fufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"pone.0319676.ref001","volume-title":"Global Tuberculosis Report 2012 on Tuberculosis, epidemiology, Tuberculosis, Pulmonary prevention, and control, Tuberculosis economic, directly observed therapy, Treatment outcome, National Health programs organization and administration, and Statistics","author":"World Health Organization"},{"key":"pone.0319676.ref002","volume-title":"Global tuberculosis report 2022","author":"World Health Organization","year":"2022"},{"key":"pone.0319676.ref003","volume-title":"WHO Global Tuberculosis Control: a short update to the 2010 report. December 2009","author":"World Health Organization","year":"2010"},{"key":"pone.0319676.ref004","volume-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2020"},{"key":"pone.0319676.ref005","volume-title":"Global tuberculosis report 2021","author":"World Health Organization","year":"2021"},{"key":"pone.0319676.ref006","first-page":"617","article-title":"Effect of isoniazid prophylaxis therapy on the prevention of tuberculosis incidence and associated factors among HIV infected individuals in northwest Ethiopia: retrospective cohort study","volume":"13","author":"MA Beshaw","year":"2021","journal-title":"HIV AIDS (Auckl)"},{"key":"pone.0319676.ref007","first-page":"1","article-title":"WHO policy on collaborative TB\/HIV activities","volume-title":"Guidelines for national programs and other stakeholders","author":"World Health Organization","year":"2012"},{"key":"pone.0319676.ref008","first-page":"385","article-title":"WHO and UNAIDS policy statement on preventive therapy against TB in people living with HIV","volume-title":"Weekly Epidemiological Record","author":"WHO\/UNAIDS","year":"1999"},{"issue":"9","key":"pone.0319676.ref009","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/00002030-200306130-00018","article-title":"Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa","volume":"17","author":"J Nachega","year":"2003","journal-title":"AIDS"},{"key":"pone.0319676.ref010","volume-title":"Implementation guideline for TB\/ HIV collaborative activities in Ethiopia","author":"FMOH","year":"2008"},{"key":"pone.0319676.ref011","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2014"},{"key":"pone.0319676.ref012","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.aids.0000391023.03037.1f","article-title":"Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions","author":"H Getahun","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"pone.0319676.ref013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199707313370505","article-title":"A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"337","author":"FM Gordin","year":"1997","journal-title":"N Engl J Med"},{"key":"pone.0319676.ref014","author":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS)"},{"key":"pone.0319676.ref015","volume-title":"Guidelines for Intensified Tuberculosis Case-Finding and IPT for PLHIV in Resource-Constrained Settings","author":"World Health Organization","year":"2011"},{"issue":"8","key":"pone.0319676.ref016","first-page":"927","article-title":"Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues","volume":"13","author":"N A\u00eft-Khaled","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"pone.0319676.ref017","first-page":"827","article-title":"Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies","volume":"119","author":"GW Comstock","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"pone.0319676.ref018","unstructured":"West Shewa Zonal Health Office Annual Report. 2018."},{"issue":"10","key":"pone.0319676.ref019","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.5588\/ijtld.15.0230","article-title":"Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(\u00ae) MTB\/RIF","volume":"19","author":"MW Adelman","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0319676.ref020","first-page":"93","volume-title":"FMOH Guideline National for Comprehensive HIV Prevention, Care and Treatment","year":"2017"},{"issue":"1","key":"pone.0319676.ref021","first-page":"1","article-title":"Intensified tuberculosis case finding, implementation of isoniazid preventive therapy and associated factors among people living with human immunodeficiency virus at public health facilities of Harari Region, Eastern Ethiopia: a cross-sectional study","volume":"11","author":"A Geleto","year":"2017","journal-title":"Int J Health Sci (Qassim)"},{"key":"pone.0319676.ref022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2458-14-52","article-title":"Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study","volume":"14","author":"AW Denegetu","year":"2014","journal-title":"BMC Public Health"},{"issue":"2","key":"pone.0319676.ref023","first-page":"109","article-title":"Screening and case detection for tuberculosis among people living with HIV in Addis Ababa, Ethiopia","volume":"47","author":"A Wesen","year":"2009","journal-title":"Ethiop Med J"},{"key":"pone.0319676.ref024"},{"key":"pone.0319676.ref025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s13104-015-1664-0","article-title":"TB\/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective study","volume":"8","author":"D Mekonnen","year":"2015","journal-title":"BMC Res Notes"},{"key":"pone.0319676.ref026","volume-title":"Tuberculosis Update in Ethiopia. Progress in 2014","author":"WHO Country Office for Ethiopia","year":"2015"},{"issue":"9","key":"pone.0319676.ref027","doi-asserted-by":"crossref","first-page":"3000605211046133","DOI":"10.1177\/03000605211046133","article-title":"Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, southwest Ethiopia: a retrospective study design","volume":"49","author":"M Aboma","year":"2021","journal-title":"J Int Med Res"},{"issue":"3","key":"pone.0319676.ref028","first-page":"192","article-title":"The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong","volume":"16","author":"CK Chan","year":"2010","journal-title":"Hong Kong Med J"},{"issue":"10","key":"pone.0319676.ref029","first-page":"591","article-title":"Frequency of dual tuberculosis\/human immunodeficiency virus infection in patients presenting at tertiary care centers at karachi","volume":"17","author":"AR Memon","year":"2007","journal-title":"J Coll Physicians Surg Pak"},{"key":"pone.0319676.ref030","first-page":"7","article-title":"TB\/ HIV co-infection in Georgia","author":"P Gabunia","year":"2008","journal-title":"Georgian Med News"},{"issue":"5","key":"pone.0319676.ref031","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e318196761c","article-title":"Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia","volume":"50","author":"S Shah","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0319676.ref032","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2334-14-148","article-title":"Tuberculosis among people living with HIV\/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors","volume":"14","author":"B Karo","year":"2014","journal-title":"BMC Infect Dis"},{"key":"pone.0319676.ref033","author":"World Health Organization (WHO)"},{"issue":"8","key":"pone.0319676.ref034","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3855\/jidc.5667","article-title":"Prevalence and determinants of Tuberculosis among HIV infected patients in south Ethiopia","volume":"9","author":"S Fekadu","year":"2015","journal-title":"J Infect Dev Ctries"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:30:35Z","timestamp":1741627835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319676"}},"subtitle":[],"editor":[{"given":"Rebecca F.","family":"Baggaley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319676","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}